Global Biomarker Research Services Market Insights Forecasts to 2030

• The global biomarker research services market was valued at USD 5,897 Million in 2021.
• The market is growing at a CAGR of 14% from 2022 to 2030
• The global biomarker research services market is expected to reach USD 19,176 Million by 2030
• The Asia Pacific is expected to grow the fastest during the forecast period

The global biomarker research services market is expected to reach USD 19,176 Million by 2030, at a CAGR of 14% during the forecast period 2022 to 2030. The biomarker research services market has grown due to the strong demand that has been generated for sophisticated and effective biomarkers as a result of the increasing prevalence of cancer, neurological disorders, and cardiovascular diseases worldwide.

Additionally, the market is being boosted by increased attention and the need for early and accurate diagnoses to enable quick and timely therapeutic treatment for a variety of chronic illnesses.

Market Overview

In order to anticipate and describe the disease, biomarkers are being employed more often worldwide. The demand for biomarkers research services in the development and validation of new biomarkers is anticipated to increase dramatically as the focus on biomarkers increases. Several contracts with research businesses offer biomarker research services for the discovery, development, validation, and testing of biomarkers. The most typical services involve the identification of a person’s biomarker, its qualification and verification, research assay optimization, and commercialization. Utilizing effective biomarkers can help significantly increase the effectiveness of recommended treatments, improve the detection of cancer biomarkers, and boost diagnostics.

Another reason that is projected to drive demand in the global market for biomarker research services in the upcoming years is the expansion of companion diagnostics' therapeutic applications in the broader field of personalized medicine. The global biomarker research services market is seeing increased demand due to technological developments and rising pharmaceutical industry demand for help with drug discovery and clinical research processes.

However, the incapacity of biotechnology and pharmaceutical companies to perform biomarker research as well as the high cost associated with research necessary for the development of new drugs could constrain the expanding global biomarker research services market in the near future. Low cost-to-benefit ratio, technical difficulties with sample collection and storage, and unsuitable regulatory and reimbursement systems are additional possible barriers that may affect the growth of the worldwide biomarker research services market in the upcoming years.

Report Coverage

This research report categorizes the market for global biomarker research services based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global biomarker research services market.

Recent market developments and competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each global biomarker research services market sub-segments.

Segmentation Analysis

• In 2021, the biomarker research services segment dominated the market with the largest market share of 55% and market revenue of 3,243 million.

Based on the service type, the global biomarker research services market is categorized into Biomarker Research Services and CDx Research Services. In 2021, the biomarker research services segment dominated the market with the largest market share of 55% and market revenue of 3,243 million.

Due to some characteristics of biomarkers, such as their rapid identification of specific diseases, the use of biomarkers research services is growing. Numerous neurological conditions, metabolic issues, immune system dysregulation, and oncological conditions are treated with biomarkers. These aid in the early diagnosis of illnesses including cancer and Alzheimer's.

In addition, biomarkers are utilized to identify Cystic Fibrosis, Huntington's disease, inherited Hemochromatosis, and infant hemolytic illness. In instance, the first diagnostic blood test for traumatic brain injury, known as Banyan BTI, was approved for sale by the U.S. Food and Drug Administration (FDA) in February 2018.

• In 2021, the cancer segment accounted for the largest share of the market, with 29% and a market revenue of 1,710 million.

Based on the disease indication, the biomarker research services market is categorized into Cardiovascular Disorders, Cancer, Infectious Diseases, Immunological Disorders, Neurological Disorders, and Others. In 2021, the cancer segment accounted for the largest share of the market, with 29% and a market revenue of 1,710 million.

The growth in demand for quick and accurate diagnostic technologies, the rising incidence of cancer worldwide, and the unmet need for more specialized, individualized therapy targets for cancer patients all contribute to the growth of the cancer segment. The market is anticipated to be driven by its application in early cancer detection, prognosis estimation, and treatment response monitoring. According to the American Cancer Society, 1.8 million new cases of the disease were recorded in 2020, and 606,520 people in the country passed away from it.

• In 2021, the hospital’s segment accounted for the largest share of the market, with 38% and a market revenue of 2,240 million.

Based on the end-user, the biomarker research services market is categorized into Hospitals, Diagnostic Centers, and Specialty Centers. In 2021, the hospital’s segment accounted for the largest share of the market, with 38% and market revenue of 2,240 million. Hospitals often have an emergency department or trauma center to handle life-threatening circumstances since they treat a wide variety of illnesses and injuries.

Regional Segment Analysis of the Biomarker Research Services Market

• North America (U.S., Canada, Mexico)
• Europe (Germany, France, the U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America)
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America emerged as the largest market for the global biomarker research services market, with a market share of around 36.1% and 5,897 million of the market revenue in 2021.

• In 2021, North America emerged as the largest market for the global biomarker research services market, with a market share of around 36.1% and 5,897 million of the market revenue. North America is expected to be the largest market.
• The major factors propelling the biomarker research services market in North America are an increase in the demand for biomarkers for disease diagnosis, companion diagnostic research for new drug development, and an increase in the prevalence of chronic diseases. In addition, the presence of major players involved in mergers and acquisitions, collaboration with CROs for biomarkers, and an increase in corporate R&D spending.
• The Asia-Pacific market is expected to grow at the fastest CAGR between 2021 and 2030, because this region is home to well-known research institutions and industrial firms. In addition, the market is anticipated to increase quickly as a result of the rapid expansion in the availability of biomarker testing.

Competitive Landscape

The report offers the appropriate analysis of the key organizations/companies involved within the global biomarker research services market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis.

The report also provides an elaborative analysis focusing on the companies' current news and developments, including product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Market Players:

• F. Hoffmann-La Roche Ltd.
• Abbott Laboratories
• Epigenetics AG
• General Electric
• Johnson & Johnson Services, Inc.
• Thermo Fisher Scientific, Inc.
• Bio-Rad Laboratories, Inc.
• Siemens Healthineers AG
• Qiagen

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities
• Consulting And Research Firm
• Venture capitalists
• Third-party knowledge providers
• Value-Added Resellers (VARs)

Some of the Key Developments:

• In February 2022, The "Neurofilament as a Fluid Biomarker of Neurodegeneration in Familial Frontotemporal Degeneration (FTD)" project, which was started by the Foundation the National Institutes of Health (FNIH) Biomarkers Consortium, will determine the most effective blood tests to measure a protein that is essential for the early detection of rare neurodegenerative diseases.

• In February 2022, With the use of the kit, laboratories with NGS capabilities may do thorough biomarker testing, offer powerful data analysis, and assist oncologists in providing the most efficient and individualized cancer treatments.

Market Segment

This study forecasts global, regional, and country revenue from 2019 to 2030. Spherical Insights has segmented the global biomarker research services market based on the below-mentioned segments:

Global Biomarker Research Services Market, By Service Type

• Biomarker Research Services
• CDx Research Services

Global Biomarker Research Services Market, By Disease Indication

• Cardiovascular Disorder
•  Cancer
• Infectious Disease
• Immunological Disorder
• Neurological Disorder
•  Others

Global Biomarker Research Services Market, By End-User

• Hospitals
• Diagnostic Centers
• Specialty Centers

Global Biomarker Research Services Market, Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • Uk
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of Middle East & Africa